Skip to main content

NEW REPORT: Texas Mifepristone Abortion Case Threatens Entire Drug Approval Process

By March 15, 2023No Comments

Read the Report Here.

Washington, DC — Today, Protect Our Care is releasing a report detailing the disastrous implications of the medical abortion lawsuit in Texas aiming to ban the abortion medication mifepristone. A decision to ban mifepristone would threaten millions of women’s access to safe and legal abortions and open the door for the politically-motivated destruction of the entire drug approval process.

Since the Supreme Court’s elimination of the constitutional right to an abortion, anti-abortion activists have ramped up their attacks on remaining protections. This attack in Texas comes at a huge cost, not only to the access to safe abortion care but to the entire U.S. drug approval process. Protect Our Care’s new report outlines the dire consequences of Judge Matthew Kacsmaryk’s potential ruling.  

Protect Our Care Founder Leslie Dach issued the following statement: 

“The medical abortion case being argued today in Texas endangers the health of millions of women and also threatens the entire drug approval process in the United States. If the judge decides to overturn the FDA approval of mifepristone, it would open the door to other politically motivated lawsuits that could result in the banning of critical life-saving drugs relied on by millions. The result would be chaos in our drug approval system and the arbitrary banning of drugs that keep so many of us alive and healthy.”